Position in ONC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$586,752
-$54,108 QoQ
Shares Held
2,059
-4.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#145
of 282 holders
Holding Since
Dec 2022
9 quarters on record
Voting authority
Sole 24%
Shared 8%
None 68%
Common Shares in ONC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cerity Partners LLC holds $424,897,823 across 139 Biotechnology names. ONC ranks #52 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
255,874 | $127,100,291 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
797,119 | $69,309,495 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
343,589 | $26,892,710 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
39,274 | $24,488,909 | |
| 5 | INCY |
Incyte Corp
|
205,071 | $23,246,847 | |
| 6 | EXEL |
Exelixis, Inc.
|
377,130 | $20,519,642 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
53,534 | $12,900,087 | |
| 8 | RPRX |
Royalty Pharma plc
|
180,772 | $10,135,884 |
All Filings in ONC
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $586,752 | 2,059 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $640,860 | 2,158 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $658,355 | 2,167 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $269,153 | 790 | Shares | Sole | 2025-10-22 | |
| 2023-12-31 | $392,102 | 2,174 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $408,484 | 2,271 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $440,935 | 2,473 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $629,778 | 2,922 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $609,233 | 2,770 | Shares | Sole | 2023-02-15 | |
| No filing history on record for this holder in this stock. | ||||||